HARMONY Alliance newsletter: Latest updates in February 2020

Newsletter 2/2020

Over the past 2 years, the HARMONY Alliance has evolved to become one of Europe’s leading initiatives for Big Data in healthcare. With the support of 100 partnering organizations, we have so far identified data sets from 45,000 patients with blood cancer. The HARMONY Big Data Platform processes these data using Big Data Analytics, in order to generate evidence that can be used to answer critical research questions in hematology. In 2020, we look forward to collaborating with more partners to gather even more meaningful insights across seven blood cancers.

Does your institution have data to contribute to HARMONY? Contact us today to become a part of HARMONY’s mission!

Watch our journey so far

Since its launch in January 2017, HARMONY has grown considerably in both size and scientific standing. To illustrate our objectives and most notable accomplishments to date, we have created this short video. Please share this with your peers to help show what we do and increase awareness of Big Data innovations in Hematology.

We've updated our website

We’re making it easier for you to find what you are looking for. New features include:

A 'Research projects' section that provides updates across our scientific studies;

A 'Big Data Platform' section that explains how we are using artificial intelligence to progress the field of hematology;

A 'Results' page with HARMONY’s scientific publications, posters and resources.

Where to meet us

HARMONY will be attending key European congresses throughout the year. Contact us today to arrange a one-to-one meeting at the following events:

EBMT Annual Meeting, March 22 –25, 2020, Madrid, Spain

ELN 17th Symposium, March 31, 2020, Mannheim, Germany

EMN 2nd Meeting, April 16–18, Amsterdam, the Netherlands

EHA 25th Anniversary Congress, June 11–14, 2020, Frankfurt, Germany

62nd ASH Annual Meeting, December 5–8, 2020, San Diego, USA

Click here to see what other meetings HARMONY is holding or participating in and join us there!

Public-private partnership for Big Data in Hematology

HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).